Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research

About this update from Quantum-si Incorporated

Validate multi-omics findings at the single-molecule level with Next-Gen Protein Sequencing™ BRANFORD, Conn., March 20, 2025 --( BUSINESS WIRE )-- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™ , announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how the integration of proteomics data with other omics datasets is driving new discoveries in disease research, including cancer. When: March 25, 2025, at 8 a.m. PT/11 a.m. ET Attendees will learn about: WHO: Featured speakers include: WHERE: Virtual event – registration required. HOW: To register, please complete the registration form . A confirmation email will be sent upon registration. About Quantum-Si Incorporated Quantum-Si , The Protein Sequencing Company ™ , is focused on revolutionizing the growing field of proteomics. The Company’s Platinum ® line of instruments enables Next-Gen Protein Sequencing ™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X . View source version on businesswire.com: https://www.businesswire.com/news/home/20250320735438/en/ Contacts Investor Contact Jeff Keyes Chief Financial Officer [email protected] Media Contact Katherine Atkinson SVP, Commercial Marketing [email protected]

View stock analysis, news, and events for Quantum-si Incorporated